Literature DB >> 21912425

A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

M Tohkin1, N Kaniwa, Y Saito, E Sugiyama, K Kurose, J Nishikawa, R Hasegawa, M Aihara, K Matsunaga, M Abe, H Furuya, Y Takahashi, H Ikeda, M Muramatsu, M Ueta, C Sotozono, S Kinoshita, Z Ikezawa.   

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe, cutaneous adverse drug reactions that are rare but life threatening. Genetic biomarkers for allopurinol-related SJS/TEN in Japanese were examined in a genome-wide association study in which Japanese patients (n=14) were compared with ethnically matched healthy controls (n=991). Associations between 890 321 single nucleotide polymorphisms and allopurinol-related SJS/TEN were analyzed by the Fisher's exact test (dominant genotype mode). A total of 21 polymorphisms on chromosome 6 were significantly associated with allopurinol-related SJS/TEN. The strongest association was found at rs2734583 in BAT1, rs3094011 in HCP5 and GA005234 in MICC (P=2.44 × 10(-8); odds ratio=66.8; 95% confidence interval, 19.8-225.0). rs9263726 in PSORS1C1, also significantly associated with allopurinol-related SJS/TEN, is in absolute linkage disequilibrium with human leukocyte antigen-B*5801, which is in strong association with allopurinol-induced SJS/TEN. The ease of typing rs9263726 makes it a useful biomarker for allopurinol-related SJS/TEN in Japanese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912425     DOI: 10.1038/tpj.2011.41

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  58 in total

1.  HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.

Authors:  Paola Borgiani; Davide Di Fusco; Fulvio Erba; Maria C Marazzi; Sandro Mancinelli; Giuseppe Novelli; Leonardo Palombi; Cinzia Ciccacci
Journal:  Eur J Clin Pharmacol       Date:  2013-12-10       Impact factor: 2.953

Review 2.  Clinical association between pharmacogenomics and adverse drug reactions.

Authors:  Zhi-Wei Zhou; Xiao-Wu Chen; Kevin B Sneed; Yin-Xue Yang; Xueji Zhang; Zhi-Xu He; Kevin Chow; Tianxin Yang; Wei Duan; Shu-Feng Zhou
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

3.  Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies.

Authors:  Shigeo Kamitsuji; Takashi Matsuda; Koichi Nishimura; Seiko Endo; Chisa Wada; Kenji Watanabe; Koichi Hasegawa; Haretsugu Hishigaki; Masatoshi Masuda; Yusuke Kuwahara; Katsuki Tsuritani; Kenkichi Sugiura; Tomoko Kubota; Shinji Miyoshi; Kinya Okada; Kazuyuki Nakazono; Yuki Sugaya; Woosung Yang; Taiji Sawamoto; Wataru Uchida; Akira Shinagawa; Tsutomu Fujiwara; Hisaharu Yamada; Koji Suematsu; Naohisa Tsutsui; Naoyuki Kamatani; Shyh-Yuh Liou
Journal:  J Hum Genet       Date:  2015-04-09       Impact factor: 3.172

4.  Tag SNPs for HLA-B alleles that are associated with drug response and disease risk in the Chinese Han population.

Authors:  X Liu; J Sun; H Yu; H Chen; J Wang; H Zou; D Lu; J Xu; S L Zheng
Journal:  Pharmacogenomics J       Date:  2015-03-10       Impact factor: 3.550

5.  Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis.

Authors:  Kiyonori Ito; Yuichiro Ueda; Haruhisa Miyazawa; Yoshio Kaku; Keiji Hirai; Taro Hoshino; Aoi Nabata; Honami Mori; Izumi Yoshida; Susumu Ookawara; Kaoru Tabei
Journal:  CEN Case Rep       Date:  2014-02-15

Review 6.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

7.  Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study.

Authors:  Joshua M Galanter; Christopher R Gignoux; Dara G Torgerson; Lindsey A Roth; Celeste Eng; Sam S Oh; Elizabeth A Nguyen; Katherine A Drake; Scott Huntsman; Donglei Hu; Saunak Sen; Adam Davis; Harold J Farber; Pedro C Avila; Emerita Brigino-Buenaventura; Michael A LeNoir; Kelley Meade; Denise Serebrisky; Luisa N Borrell; William Rodríguez-Cintrón; Andres Moreno Estrada; Karla Sandoval Mendoza; Cheryl A Winkler; William Klitz; Isabelle Romieu; Stephanie J London; Frank Gilliland; Fernando Martinez; Carlos Bustamante; L Keoki Williams; Rajesh Kumar; José R Rodríguez-Santana; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-01-07       Impact factor: 10.793

Review 8.  Relating human genetic variation to variation in drug responses.

Authors:  Ashraf G Madian; Heather E Wheeler; Richard Baker Jones; M Eileen Dolan
Journal:  Trends Genet       Date:  2012-07-26       Impact factor: 11.639

9.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

10.  A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.

Authors:  Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung-Ki Han; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Sejung Sohn; Todd A Johnson; Atsushi Takahashi; Michiaki Kubo; Tatsuhiko Tsunoda; Kaoru Ito; Yoshihiro Onouchi; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  J Hum Genet       Date:  2017-08-31       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.